US EditionSERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE
- Sera Prognostics Inc., specializing in maternal and neonatal health diagnostics, is scheduled to participate in the RBC Global Healthcare Conference in Salt Lake City on May 21, 2025.
- The presentation follows a PRNewswire announcement on May 14, 2025, confirming the event and CEO Zhenya Lindgardt's participation in a fireside chat providing a company update.
- Sera Prognostics develops blood-based pregnancy biomarker tests like PreTRM, which predicts spontaneous preterm birth risk during weeks 18 to 20 of pregnancy to assist personalized clinical decisions.
- Preterm birth, defined as birth before 37 weeks, affects over one in ten infants annually in the U.S. And contributes to $25 billion in healthcare costs due to related long-term complications.
- Sera Prognostics aims to improve maternal and newborn health while reducing healthcare costs through innovative diagnostics, with the upcoming presentation highlighting its recent progress and future plans.
Insights by Ground AI
Does this summary seem wrong?
29 Articles
29 Articles
All
Left
2
Center
11
Right
Montana Standard+28 Reposted by 28 other sources
SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE
SALT LAKE CITY , May 14, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will…
Coverage Details
Total News Sources29
Leaning Left2Leaning Right0Center11Last UpdatedBias Distribution85% Center
Bias Distribution
- 85% of the sources are Center
85% Center
15%
C 85%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
